Lv4
602 积分 2024-11-04 加入
2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain ModelClick to copy article link
3天前
已完结
Misconceptions among medicinal chemists regarding ADME and PK optimization
23天前
已完结
Identification of an Orally Bioavailable Quinoline-Based Small-Molecule Tumor Necrosis Factor α (TNF-α) Inhibitor Featuring a Spirocyclic Scaffold
24天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
25天前
已完结
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity
27天前
已完结
Chronic Myeloid Leukemia: A Review
1个月前
已完结
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
1个月前
已完结
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug
1个月前
已完结
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor
1个月前
已完结
NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease
1个月前
已完结
皖公网安备34019202002308
